State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey

Emanuele Barbato, E Shlofmitz, A Milkas, R Shlofmitz, Lorenzo Azzalini, A Colombo

Research output: Contribution to journalArticle

Abstract

© Europa Digital & Publishing 2017. All rights reserved. Since the first balloon angioplasty by Andreas Grüntzig 40 years ago, interventional cardiology has witnessed the introduction of countless tools and techniques that have significantly contributed to broadening the application of percutaneous coronary interventions (PCI) in unprecedented anatomic settings. Heavily calcified, fibrotic coronary stenosis has traditionally represented a very challenging scenario for PCI, and a very common indication for surgical revascularisation. This was mostly due to the difficulty in adequately dilating these lesions and/or to the inability to deliver and implant stents appropriately, which is often associated with high rates of procedural complications and suboptimal long-term clinical outcomes. Thanks to dedicated cutting and scoring balloons and to atherectomy devices, the treatment of most fibrotic and heavily calcified stenoses has become feasible and safe. Interventional cardiologists have learned how best to apply these tools through better patient and lesion selection, and also as a result of improved technology and techniques. In this review, we describe a 40-year-long journey that has evolved from the initial stand-alone debulking strategy to the currently applied coronary plaque modification, with the main objective of optimising drug-eluting stent delivery and implantation, translating into significantly improved patient outcomes. © Europa Digital & Publishing 2017. All rights reserved.
Original languageEnglish
Pages (from-to)696-705
Number of pages10
JournalEuroIntervention
Volume13
Issue number6
DOIs
Publication statusPublished - 2017

Fingerprint

Coronary Stenosis
Percutaneous Coronary Intervention
Atherectomy
Drug-Eluting Stents
Balloon Angioplasty
Cardiology
Patient Selection
Stents
Pathologic Constriction
Technology
Equipment and Supplies
Therapeutics
Cardiologists

Cite this

State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey. / Barbato, Emanuele; Shlofmitz, E; Milkas, A; Shlofmitz, R; Azzalini, Lorenzo; Colombo, A.

In: EuroIntervention, Vol. 13, No. 6, 2017, p. 696-705.

Research output: Contribution to journalArticle

Barbato, Emanuele ; Shlofmitz, E ; Milkas, A ; Shlofmitz, R ; Azzalini, Lorenzo ; Colombo, A. / State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey. In: EuroIntervention. 2017 ; Vol. 13, No. 6. pp. 696-705.
@article{bf5884598d0e473bae5eb22e2a4d38b9,
title = "State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey",
abstract = "{\circledC} Europa Digital & Publishing 2017. All rights reserved. Since the first balloon angioplasty by Andreas Gr{\"u}ntzig 40 years ago, interventional cardiology has witnessed the introduction of countless tools and techniques that have significantly contributed to broadening the application of percutaneous coronary interventions (PCI) in unprecedented anatomic settings. Heavily calcified, fibrotic coronary stenosis has traditionally represented a very challenging scenario for PCI, and a very common indication for surgical revascularisation. This was mostly due to the difficulty in adequately dilating these lesions and/or to the inability to deliver and implant stents appropriately, which is often associated with high rates of procedural complications and suboptimal long-term clinical outcomes. Thanks to dedicated cutting and scoring balloons and to atherectomy devices, the treatment of most fibrotic and heavily calcified stenoses has become feasible and safe. Interventional cardiologists have learned how best to apply these tools through better patient and lesion selection, and also as a result of improved technology and techniques. In this review, we describe a 40-year-long journey that has evolved from the initial stand-alone debulking strategy to the currently applied coronary plaque modification, with the main objective of optimising drug-eluting stent delivery and implantation, translating into significantly improved patient outcomes. {\circledC} Europa Digital & Publishing 2017. All rights reserved.",
author = "Emanuele Barbato and E Shlofmitz and A Milkas and R Shlofmitz and Lorenzo Azzalini and A Colombo",
year = "2017",
doi = "10.4244/EIJ-D-17-00473",
language = "English",
volume = "13",
pages = "696--705",
journal = "EuroIntervention",
issn = "1774-024X",
publisher = "EuroPCR",
number = "6",

}

TY - JOUR

T1 - State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey

AU - Barbato, Emanuele

AU - Shlofmitz, E

AU - Milkas, A

AU - Shlofmitz, R

AU - Azzalini, Lorenzo

AU - Colombo, A

PY - 2017

Y1 - 2017

N2 - © Europa Digital & Publishing 2017. All rights reserved. Since the first balloon angioplasty by Andreas Grüntzig 40 years ago, interventional cardiology has witnessed the introduction of countless tools and techniques that have significantly contributed to broadening the application of percutaneous coronary interventions (PCI) in unprecedented anatomic settings. Heavily calcified, fibrotic coronary stenosis has traditionally represented a very challenging scenario for PCI, and a very common indication for surgical revascularisation. This was mostly due to the difficulty in adequately dilating these lesions and/or to the inability to deliver and implant stents appropriately, which is often associated with high rates of procedural complications and suboptimal long-term clinical outcomes. Thanks to dedicated cutting and scoring balloons and to atherectomy devices, the treatment of most fibrotic and heavily calcified stenoses has become feasible and safe. Interventional cardiologists have learned how best to apply these tools through better patient and lesion selection, and also as a result of improved technology and techniques. In this review, we describe a 40-year-long journey that has evolved from the initial stand-alone debulking strategy to the currently applied coronary plaque modification, with the main objective of optimising drug-eluting stent delivery and implantation, translating into significantly improved patient outcomes. © Europa Digital & Publishing 2017. All rights reserved.

AB - © Europa Digital & Publishing 2017. All rights reserved. Since the first balloon angioplasty by Andreas Grüntzig 40 years ago, interventional cardiology has witnessed the introduction of countless tools and techniques that have significantly contributed to broadening the application of percutaneous coronary interventions (PCI) in unprecedented anatomic settings. Heavily calcified, fibrotic coronary stenosis has traditionally represented a very challenging scenario for PCI, and a very common indication for surgical revascularisation. This was mostly due to the difficulty in adequately dilating these lesions and/or to the inability to deliver and implant stents appropriately, which is often associated with high rates of procedural complications and suboptimal long-term clinical outcomes. Thanks to dedicated cutting and scoring balloons and to atherectomy devices, the treatment of most fibrotic and heavily calcified stenoses has become feasible and safe. Interventional cardiologists have learned how best to apply these tools through better patient and lesion selection, and also as a result of improved technology and techniques. In this review, we describe a 40-year-long journey that has evolved from the initial stand-alone debulking strategy to the currently applied coronary plaque modification, with the main objective of optimising drug-eluting stent delivery and implantation, translating into significantly improved patient outcomes. © Europa Digital & Publishing 2017. All rights reserved.

U2 - 10.4244/EIJ-D-17-00473

DO - 10.4244/EIJ-D-17-00473

M3 - Article

VL - 13

SP - 696

EP - 705

JO - EuroIntervention

JF - EuroIntervention

SN - 1774-024X

IS - 6

ER -